DRUG CHECKING PROGRAMS AS A HARM REDUCTION STRATEGY

Slides:



Advertisements
Similar presentations
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
Advertisements

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Experiences of Drug Consumption Rooms in Europe
6th Annual Progress Conference ISCH Domain 31 May – 1 June 2012 ENS Lyon.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Association for the Education of Adults EAEA European AE Research – Look towards the future ERDI General Assembly, 2004.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Sofia City of Oslo Agency for Alcohol and Drug Addiction Services/Competence Centre Agency for Alcohol and Drug Addiction Services, Competence.
1 Science and Society: EU Strategy and actions Dr. Rainer GEROLD Director Science and Society Research DG European Commission.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Washington D.C., USA, July 2012www.aids2012.org The HIV/AIDS Civil Society Forum and Think Tank: from policy to action Anna Zakowicz HIV/AIDS Civil.
Coordination and Net Working on DRR Rapid Emergency Assessment and Coordination Team (REACT) Bishkek November, 2009.
Alcohol policy in Catalonia Joan Colom Antoni Gual Lidia Segura March 2007, Pécs, Baranya (H)
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
European Commission Camilla SANDVIK DG SANCO / G/ 3 The European Union and Nutrition Presentation at European Health Forum, Gastein 26 September 2002 Camilla.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
Substance Abuse Prevention Fulfilling the Promise Linda Dusenbury, Ph.D. Tanglewood Research.
LOCAL PASS A Local approach towards the reduction of PsychoActive Substance uSe Renée Otte February 5, 2015.
WHO activities related to WHA58.26 | 11. August |1 | WHA resolution on alcohol (2005): background and follow up activities by the WHO Secretariat.
TEDI TEDI Trans European Drug Information Mireia Ventura – Energy control Barcelona Alexander Bücheli – City of Zurich youth counseling Streetwork.
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
PREVENTION OF DRUG ABUSE AMONG VULNERABLE GROUPS Dr Marcus Roberts Director of Policy and Membership DRUGSCOPE.
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
THE SOUND OF SILENCE: AN EVALUATION OF CDC’S PODCAST INITIATIVE Quynh-Chau, M., Myers, Bradford A. (2013). The Sound of Silence: an evaluation of CDC's.
Designer Drugs/Club Drugs Club drugs are synthetic, illegal drugs produced in underground labs that change the molecular structure of an existing drug.
DRUG CHECKING TUTORIAL
Magali Martinez, Agnès Cadet-Taïrou TREND UNIT, OFDT
Dagur B. Eggertsson, Mayor of Reykjavík
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
Partnerships for success (PFS)
EU tobacco and nicotine regulations - general aspects
Risk Communication in Medicines
MIREIA VENTURA VILAMALA, PhD
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Business sector engagement and Consumer Awareness October 3rd, 2017
PMMA (paramethoxymethamphetamine) in “legal highs” in Spain
Musculoskeletal Health in Europe
Designer Drugs/Club Drugs
Bath Salts.
NPN Workshop Overview and Implications for Prevention
Nisa, A.*, Carvalho, H*#, Castro, D*., Carvalhinho, S.*
THE GERMAN NEW PSYCHOACTIVE SUBSTANCE LAW (NPSG): PERCEIVED AND EXPECTED OUTCOMES IN THE FIRST STAGE OF IMPLEMENTATION. Tessa-Virginia Hannemann.
“CareerGuide for Schools”
The social epidemiology of alcohol and drug use among Israeli school-aged children: Recent developments and current challenges Prof. Yossi Harel-Fisch.
New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM):
Results of an international drug testing service for cryptomarket users Mireia Ventura· ABD – Energy Control 15th May 2017.
Lisbon Addictions 2017 Liv Flesland, Consultant
Bath Salts.
CCMI 9 September 2015 Public Hearing: Nanotechnology for a competitive chemical industry Social aspects: education, health and safety.
Symptoms and correlates of emergency medical treatment following the use of MDMA Dr. Larissa J. Maier Monica J. Barratt, Jason A. Ferris, & Adam R. Winstock.
Comparison of data from WBE with other sources
A Spanish Drug Checking service for recreational drug users
New Psychoactive Substances in Portugal
Designer Drugs/Club Drugs
Chapter 5 Promoting youth health and wellbeing
Cerdá M, Wall M, Feng T, et al
Legalization of Drugs The Dutch experience.
About the Strategy The Domino Strategy™ is a harm reduction, social marketing campaign that encourages the public to pay attention to the size, content.
Social services for the active inclusion of disadvantaged people
The spirit of the CIVITAS mobility measure evaluation
Online health and community indicator platforms
WORKSHOP “Emerging environmental pollutants: key issues and challenges” Stresa, Italy June 2006.
Chapter 2 Strategies for promoting physical activity & the Strategies of Change Model.
Skopje, 21 November 2017, General Population Survey results– launch
Transnational access HIVA KU Leuven) Expertise in indicators and comparative analysis about quality of work at EU level research infrastructure About.
Main pathological problems in the Czech Republic
Risk Reduction on New Drugs,
TEDI project (Trans European Drug Information)
Presentation transcript:

DRUG CHECKING PROGRAMS AS A HARM REDUCTION STRATEGY Mireia Ventura, Ph.D Bruxelles, 1st Forum Science and Society dialogue in the field of drugs 4th of December 2012

Problem analysis } Drug use statistics estimate that approximately 14.5 million Europeans have used cocaine at least once in their lives (4.3% of adults aged 15–64 years), 12.5 million have tried amphetamines and some 11 million have tried ecstasy1. } Most of the countless recreational substances currently available, except alcohol, are illegal throughout Europe. One of the adverse effect of these conditions is that illegal drugs are often cut or replaced with other, mostly cheaper substances to increase profits. Some examples are the different fatal cases reported in Europe with PMMA2 sold as ecstasy or 4-Methylamphetamine sold as Amphetamine3. 2011, EMCDDA, Statistical Bulletin. EMCDDA. (2003). Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. EMCDDA. (2012).Europol Joint Report on a new psychoactive substance: 4-methylamphetamine.  

Problem analysis } Fortunately, in most cases this risk does not become lethal, although the presence of adulterants that have a long term toxicity is habitual. } In 2009 it was reported in the U.S. and Canada the occurrence of agranulocytosis associated with cocaine adulterated with levamisole 4,5. Since that, levamisole has been detected as adulterant of cocaine in many countries of Europe. } Levamisole is an immunosuppressive substance which could provoke serious health problems to regular cocaine users.   4. Knowles, L. et al. (2009). Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduction Journal. 6:30. 5. Zhu, NY., Legatt, DF. and Turner, AR. (2009) Agranulocytosis after consumption of cocaine adulterated with levamisole. Annual Internal Medicine, 50(4), 287-9.  

Problem analysis } Even if the substances are pure, there is a risk related to the dosage. One example are high dose ecstasy pills. } In terms of neurotoxicity of Ecstasy, scientific studies pointed out that the probability for possible neurotoxic damage in the serotonergic system grows with the amount of MDMA being consumed6. } Furthermore, it has been suggested that a proportion of the harms associated with ecstasy use (e.g., increased toxic effects) can be attributed to psychoactive ingredients other than MDMA that are contained within pills sold as ecstasy 7, 8.   6. Cuyàs, E. et.al. (2011). The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance. PLoS One. 6(11). 7. Parrot, A.C. (2004). Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology.173(3-4), 234-41.  8. Vanattou-Saïfoudine, N., McNamara ,R. and Harkin A. (2012). Caffeine provokes adverse interactions with MDMA (“Ecstasy”) and related psychostimulants: mechanisms and mediators. British Journal of Pharmacology, 167(5), 946-59.  

Drug Checking as a harm reduction strategy } A Drug Checking service represents a direct response to the need to reduce these health risks of illegal drug use. } Drug Checking results show that illegal drugs varies greatly and with regional differences with regard to their levels of purity and the number and percentage of adulterants . Every country shows its own unique drug market composition and dynamic9,10. } Moreover, Drug Checking assists authorities in fulfilling their mandate to contribute to an early warning system by gathering data from the actual substances and drugs consumed and not solely from the often unadulterated substances seized by in police raids.  9. TEDI: Trans European Drug Information. (2012). First TEDI trend report. Available in: http://www.tediproject.org/uploads/trend_reports_file_1342521771.pdf 10. Brunt TM, Niesink RJ (2011). The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison. Drug Testing and Analysis. 3(9):621-34  

What is a Drug Checking service? } The term “Drug Checking” refers to an integrated service that basically enables drug users to have their synthetic drugs (e.g., cocaine, ecstasy, GHB, or LSD) chemically analysed as well as receiving advice, and, if necessary, counselling. } Drug Checking represents an essential aspect of public health policy as recommended by the World Health Organization and has been further developed by both EU agencies and various European nations. } An integrated Drug Checking service creates awareness about a drug’s effects and side effects, educates users about the methods of harm reduction, and thereby reduces the risks for drug users. Moreover, substance alerts can reveal the risks of drug use to a larger audience.

Main goals General Drug Checking aims at minimizing the short- and long-term adverse health effects of illegal drug use. Specifics } Use Drug checking programs as an educational and harm/risk reduction tool by getting in touch with consumers and providing them with individual and personalized information about the substance they may consume. } Use Drug Checking programs to help make contact with drug consumers that would not normally approach drug programs by providing peer focus interventions that suit the needs of the party scene and work well within the locations where drug use is focused. } Monitor the illegal market detecting new trends of drugs and drugs use and make this information available to all stakeholders involved.

Contact with drug users } Drug Checking services contact with users with high lifetime prevalences, high consumption frequency, polydrug use and negative experiences. Users of a Drug Checking service are individuals with high (risky) or even dependent consumption 11.   } For many users Drug Checking is often the first point of contact with the social support system. By offering these consumers a specific service (substance analysis) it is easier to motivate them to participate in a consultation or a counselling session 11. 11. Hungerbuehler, I., Buecheli, A., Schaub, M. (2011) Drug Checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use – evaluation of Zurich’s drug checking services. Harm Reduction Journal, 8:16.

Contact with drug users Conditions: } Pass the information on in a neutral, non- moralising and non-judgmental manner without patronising or alarming the visitors. } Anonymity of the drug user has to be guaranteed, this is one of the main conditions of keeping these services trustworthy for drug users. Young drug users often dismiss government messages as tendentious and untrustworthy and are better persuaded by personal contact with well-informed peers or professionals10. 10. Brunt TM, Niesink RJ (2011). The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison. Drug Testing and Analysis. 3(9):621-34

Contact with drug users } Research involving three nations reveals that integrated drug testing methods do not stimulate increased drug use and may even slightly reduce drug-use levels among the target audience12. } Warnings issued regarding a particular drug, after chemical analysis, can have far-reaching and positive effects on those most closely involved in drug use. Evaluations of the Party Drug Prevention in the City of Zurich shows that since Drug Checking was implemented, the number of people who consume more than one drug or abuse one substance is on the decline13. 12. Benschop, A., Rabes M. and Korf D.J.( 2002). Pill Testing – Ecstasy & Prevention, Niedersachsische Landesstelle Suchtgefahren, Germany. 13. Bücheli, A. Quinteros–Hungerbühler, I. Schaub, M. (2010). Evaluation of Party Drug Prevention in the City of Zurich, 16(8), 38-43.

Can a Drug Checking service be an adequate response to lethal drugs? In the first stage, it provides information about the potential danger of a particular drug to the users. Research reveals that users consider the information provided by the Drug Checking team as very trustworthy14 . 2. The second phase involves the dissemination of this information in the warning campaigns. One example of the effectiveness of networking was the one performed in 2009 due to a Research Chemical wrongly labeled. When the result of the analysis was spread through a website like Erowid and thorough the contacts of EMCDDA, the deaths stopped. 14. 2006, Johnston, J.et al., “A survey of regular ecstasy users’ knowledge and practices around determining pill content and purity: Implications for policy and practice,” International Journal of Drug Policy, 17, 464-472.  

Types of Drug Checking services Mobil (on site): Drug Checking facility at raves, clubs, festivals or public spaces. Mostly together with an information stand and/or chill out and with consultation services. Types of Drug Checking services } Mobile (on site): Drug Checking facility at raves, clubs, festivals or public spaces. Mostly together with an information stand and/or chill out and with consultation services. } Regular in a Centre: Drug Checking facility for analysing or for collecting substances that later will be analyzed in a external laboratory. It’s open regularly one day a week. It’s mostly integrated in prevention or information Centre together with consultation and counselling services.

Different Drug Checking techniques Different methods can be used for analysing drugs, the ones used in Europe are: } Marquis test and other colorimetric tests } Thin Layer Chromatography (TLC) } High Pressure Liquid Chromatography (HPLC) } Gas Chromatography (GS) } Mass Spectrometry (MS) } Nuclear Magnetic Resonance (NMR)

Drug Checking in Europe At the moment seven European countries have Drug Checking facilities, and around 14’000 samples are analysed every year. Drug Checking in Europe Médecins du Monde At this moment seven European countries have Drug Checking facilities, and around 14.000 samples are analysed every year.

What is TEDI? The Trans European Drug Information project (TEDI) is a network of European fieldwork Drug Checking services that share their expertise and data within a European monitoring and information system. TEDI’s chief aim is to improve public health and intervention programs. Toward this goal, TEDI has developed a database system that collects, monitors and analyses the evolution of various European drug trends in recreational settings. Besides its Drug Checking information function, TEDI project also focuses on: Standardising the various processes related to Drug Checking Making recommendations to help improve first-line project field interventions Monitoring the evolution of new substances and new trends throughout Europe.

Conclusions } Individual, directed, harm-reduction advice serves the needs of existing users better than simply promoting abstention. The one-on-one contacts the users have with the personnel at Drug checking services, combined with factual information concerning their drug purchase and other drugs circulating the streets largely meets the information needs of drug users. } A Drug Checking service attracts a heterogeneous risk consumption group, introducing early intervention to a group of drug users who are usually in the earlier stages of their ‘drug careers’ and who have not previously sought out the services offered by a substance abuse organisation.

Conclusions } A Drug Checking service increases the effectiveness of the response when new or lethal drugs emerges. } With the aim that nations will be able to more effectively address the issue of rapid detection of the dissemination of dangerous substances and the introduction of new drugs into Europe TEDI network has been created.

CONTACT : Mireia Ventura TEDI Manager mireia@energycontrol.org www.tediproject.org